Banque Pictet & Cie’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,120	Closed	-$445K	–	391
2025 Q4	$445K	Sell	1,120 -265	-19%	-$117K	﹤0.01%	310
2025 Q3	$632K	Sell	1,385 -6	-0.4%	-$2.44K	0.01%	292
2025 Q2	$454K	Sell	1,391 -92	-6%	-$25.5K	﹤0.01%	296
2025 Q1	$400K	Buy	+1,483	New	+$381K	﹤0.01%	326
2024 Q2	–	Sell	-33,005	Closed	-$4.93M	–	300
2024 Q1	$4.93M	Buy	33,005 +10,176	+45%	+$1.7M	0.05%	149
2023 Q4	$4.37M	Sell	22,829 -2,595	-10%	-$442K	0.05%	161
2023 Q3	$4.5M	Sell	25,424 -1,154	-4%	-$220K	0.05%	152
2023 Q2	$5.05M	Buy	26,578 +21,471	+420%	+$4.26M	0.04%	166
2023 Q1	$1.02M	Sell	5,107 -2,316	-31%	-$487K	0.01%	381
2022 Q4	$1.76M	Sell	7,423 -4,910	-40%	-$1.05M	0.02%	308
2022 Q3	$2.47M	Buy	12,333 +4,991	+68%	+$952K	0.03%	253
2022 Q2	$1.07K	Sell	7,342 -4,432	-38%	-$629K	0.01%	419
2022 Q1	$1.92M	Sell	11,774 -4,707	-29%	-$717K	0.01%	341
2021 Q4	$2.79M	Buy	+16,481	New	+$3.06M	0.02%	283